Advisory Research’s Twist Bioscience TWST Stock Holding History

Advisory Research’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-35,981	Closed	-$1.33M	–	311
2023 Q4	$1.33M	Buy	35,981 +25,603	+247%	+$592K	0.2%	132
2023 Q3	$210K	Sell	10,378 -10,745	-51%	-$236K	0.03%	417
2023 Q2	$432K	Buy	+21,123	New	+$316K	0.06%	308
2022 Q3	–	Sell	-13,552	Closed	-$473K	–	404
2022 Q2	$473K	Buy	+13,552	New	+$480K	0.05%	235
2021 Q2	–	Sell	-8,690	Closed	-$1.08M	–	384
2021 Q1	$1.08M	Buy	8,690 +4,431	+104%	+$673K	0.08%	197
2020 Q4	$602K	Sell	4,259 -5,955	-58%	-$661K	0.04%	244
2020 Q3	$776K	Sell	10,214 -16,178	-61%	-$1.01M	0.08%	200
2020 Q2	$1.2M	Buy	26,392 +4,867	+23%	+$175K	0.11%	153
2020 Q1	$658K	Buy	+21,525	New	+$579K	0.05%	166
2019 Q4	–	Sell	-15,877	Closed	-$379K	–	344
2019 Q3	$379K	Buy	+15,877	New	+$462K	0.02%	276

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Advisory Research's TWST Position: Q1 2024 in Review

Advisory Research sold out of Twist Bioscience (TWST) in Q1 2024, closing a stake of 35,981 shares — an estimated $1.33M sold.

Advisory Research first reported a position in TWST in Q3 2019 and held it in 10 quarters. The position peaked at $1.33M in Q4 2023. 237 funds tracked by Wall St. Rank hold TWST as of Q1 2024.

Advisory Research reported no remaining Twist Bioscience position as of Q1 2024 after selling out during the quarter.
Advisory Research sold 35,981 Twist Bioscience shares in Q1 2024, an estimated $1.33M.
Advisory Research first reported a position in Twist Bioscience in Q3 2019 and held it in 10 quarters.
Advisory Research's Twist Bioscience position peaked at $1.33M in Q4 2023.
237 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2024.

Based on Advisory Research's 13F filing for Q1 2024, filed 14 May 2024.